Regulus Therapeutics Inc. (RGLS) Gained 7.69% or 0.05 To Price $0.71 On Monday


Regulus Therapeutics Inc. (RGLS) gained 7.69% or 0.05 to $0.71. It is close to 227560 shares traded, which is 113.05% compare to the average total volume 201285. The market cap of RGLS is $74.06 million. The year to date change is -33.97%. The 52 week price range is from $0.61 to $1.52. Price of RGLS have changed -4.46% during last week. It have changed -8.44% over last month, -8.13% over last 3 months, -36.62% over last 6 months and -33.07% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RGLS is 0.70. It is -1.41% below current price. The 200-day Moving Averages for RGLS is 0.97. It is 36.62% above current price. The 52-week High is 1.52. It is 114.08% from the current price. The 52-week Low is 0.61. It is -14.08% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RGLS is 5.65 on 2018-06-15. Short % to float is 1.01%. There are some statistics of RGLS. It is has market cap $74.06 million. The share outstanding is 104.32 million. The average volume is 201285. The revenue is 36000. The percent of top 15 Institution holding is 50.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RGLS is -220.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RGLS is -95.48%.


Tags:

Share this post